Perennial Allergic Rhinitis

• CLINICAL_TRIALS research · 2007-07-25
  Clinical Trial Update: EWO1 in Persistent Allergic Rhinitis Patients [Phase 2, Phase 3]

  This document provides an update on a Phase 2/Phase 3 trial of EWO1 for perennial allergic rhinitis conducted by China Medical University Ho…

• FDA approval · 2007-07-19
  FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for CLARINEX-D 12 HOUR, a combination product of desloratadine and pseudoephedrine sulfate from …

• FDA approval · 2007-04-27
  FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Original Application (Haleon US Holdings LLC)

  FDA approved FLONASE SENSIMIST ALLERGY RELIEF (fluticasone furoate) under an original NDA from Haleon US Holdings LLC for relief of symptoms…

• FDA label_change · 2007-04-13
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the drug's labelin…

• FDA approval · 2007-04-13
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-05-19
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for Singulair (montelukast) by Organon LLC, resulting in labeling modifications related to its indic…

• FDA approval · 2006-05-19
  FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.